Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LXJDZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
FS001-VH4-VL3-Dxd
|
|||||
| Synonyms |
FS001-VH4-VL3-Dxd
Click to Show/Hide
|
|||||
| Organization |
FORESEEN TECHNOLOGY (BEIJING) CO., LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.6
|
|||||
| Antibody Name |
FS001-huVH4-huVL3
|
Antibody Info | ||||
| Antigen Name |
Glypican-3 (GPC3)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Mc-Gly-Gly-Phe-Gly
|
Linker Info | ||||
| Combination Type |
Deruxtecan
|
|||||